Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. (2013)
Attributed to:
Confidence in Concept 2012 - Cambridge
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1320318110
PubMed Identifier: 24277834
Publication URI: http://europepmc.org/abstract/MED/24277834
Type: Journal Article/Review
Volume: 110
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 50
ISSN: 0027-8424